期刊文献+

心房纤颤治疗新进展

NEW PROGRESS IN ATRIAL FIBRILLATION THERAPY
暂未订购
导出
摘要 房颤是一种常见的心律失常,其发病率随年龄的增加而升高,目前高血压、冠心病已逐渐成为老年房颤的最常见原因,现已公认房颤与脑卒中有很大关系,所以房颤病人进行转复治疗尤其抗凝治疗具特殊意义。在抗凝治疗过程中,应结合患者的年龄、临床危险因素及抗凝治疗的益处和潜在危险,合理使用抗凝药物。抗凝治疗有预防栓塞的作用。 Atrial fibrillation is happened arrhythmia frequently.The incidence of the disease will increase as the age increases.At present,hypertension,coronary heart disease are the main factors causing the aged people to catch atrial fibrillation.It has been proved that atrial fibrillation is related very much to stroke.So it is of great significance for the patients who have caught atrial fibrillation to be treated with anticoagulant therapy.as well as Cardioversion treatment.In the couse of anticoagulant therapy,the anticoagulants should be used according to the patients age,clinical danger as well as the advantage and potential danger of the anticoagulative therapy.Anticoagulative therapy plays an important role in preventing thrombosis,so as to lower the morbidity of stroke.
作者 李春玲
出处 《天津轻工业学院学报》 1999年第2期37-40,共4页 Journal of Tianjin University of Light Industry
关键词 心房纤颤 卒中 抗凝治疗 治疗 房颤 Atrial fibrillation,Stroke,Anticoagulant therapy
  • 相关文献

参考文献1

  • 1李莉.-[J].心血管病学进展,1997,4:240-240.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部